Cargando…
Smart nanomedicine agents for cancer, triggered by pH, glutathione, H(2)O(2), or H(2)S
Effective tumor diagnosis and therapy have always been a significant but challenging issue. Although nanomedicine has shown great potential for improving the outcomes of tumor diagnosis and therapy, the nonspecial targeted distribution of nanomedicine agents in the whole body causes a low diagnosis...
Autores principales: | Li, Yaping, An, Lu, Lin, Jiaomin, Tian, Qiwei, Yang, Shiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664425/ https://www.ncbi.nlm.nih.gov/pubmed/31440046 http://dx.doi.org/10.2147/IJN.S210116 |
Ejemplares similares
-
Smart pH-responsive nanomedicines for disease therapy
por: Shinn, Jongyoon, et al.
Publicado: (2022) -
Smart H(2)S‐Triggered/Therapeutic System (SHTS)‐Based Nanomedicine
por: Chen, Weiyu, et al.
Publicado: (2019) -
Ellagic acid-Fe@BSA nanoparticles for endogenous H(2)S accelerated Fe(III)/Fe(II) conversion and photothermal synergistically enhanced chemodynamic therapy
por: Tian, Qingqing, et al.
Publicado: (2020) -
CO(2)chemotransduction in central neurons: role of intracellular pH (pH(i)) and extracellular pH (pH(o))
por: Putnam, RW
Publicado: (2001) -
Smart Methylcellulose Hydrogels for pH-Triggered Delivery of Silver Nanoparticles
por: Bonetti, Lorenzo, et al.
Publicado: (2022)